Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

LEN-Seek: Fast and scalable ligand binding-site similarity search in the latent space of an SE(3)-invariant graph VAE

Created on 16 Aug 2026

Authors

Yeo, K., Kim, D., Sim, J., Lee, J.

Abstract

Motivation: Ligand binding-site similarity search is a crucial step in drug discovery that reduces the conformational search space for docking and other downstream tasks by comparing a target protein against experimentally identified binding sites. Existing methods rely on either direct structural alignment or lossy compression of structural information, producing a trade-off between scalability and precision. Results: We propose LEN-Seek, a ligand binding-site search method based on a graph neural network (GNN)-driven variational autoencoder (VAE) that encodes the 3D structural and physicochemical context of a binding site into a probabilistic latent space, enabling similarity search within a low-dimensional vector space. A binding site is modeled as a graph of amino acid residues, with node features adopted from the protein language model, Ankh, and edges encoded as SE(3)-invariant (roto-translational invariant) geometric relationships, thereby avoiding expensive data augmentation or SE(3)-equivariant models. Compared to ProBiS, the purely geometric graph-clique based method, LEN-Seek successfully retrieves a substantial portion of similar binding sites with a roughly 3,400-fold lower per-comparison cost, demonstrating its potential as a scalable approach to template-based ligand binding-site search in large-scale protein structure databases.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 16 Aug 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 2
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement